|
US2699508A
(en)
|
1951-12-21 |
1955-01-11 |
Selectronics Inc |
Method of mounting and construction of mounting for low frequency piezoelectric crystals
|
|
US3687808A
(en)
|
1969-08-14 |
1972-08-29 |
Univ Leland Stanford Junior |
Synthetic polynucleotides
|
|
US5118800A
(en)
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
Oligonucleotides possessing a primary amino group in the terminal nucleotide
|
|
FR2567892B1
(fr)
|
1984-07-19 |
1989-02-17 |
Centre Nat Rech Scient |
Nouveaux oligonucleotides, leur procede de preparation et leurs applications comme mediateurs dans le developpement des effets des interferons
|
|
US5367066A
(en)
|
1984-10-16 |
1994-11-22 |
Chiron Corporation |
Oligonucleotides with selectably cleavable and/or abasic sites
|
|
FR2575751B1
(fr)
|
1985-01-08 |
1987-04-03 |
Pasteur Institut |
Nouveaux nucleosides de derives de l'adenosine, leur preparation et leurs applications biologiques
|
|
US4751219A
(en)
|
1985-02-05 |
1988-06-14 |
Nederlandse Centrale Organisatie Voor Toegepast-Natuur-Wetenschappelijk Onderzoek |
Synthetic glycolipides, a process for the preparation thereof and several uses for these synthetic glycolipides
|
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
|
US5166315A
(en)
|
1989-12-20 |
1992-11-24 |
Anti-Gene Development Group |
Sequence-specific binding polymers for duplex nucleic acids
|
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
|
US5185444A
(en)
|
1985-03-15 |
1993-02-09 |
Anti-Gene Deveopment Group |
Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
|
|
CA1340032C
(en)
|
1987-06-24 |
1998-09-08 |
Jim Haralambidis |
Lucleoside derivatives
|
|
US5175273A
(en)
|
1988-07-01 |
1992-12-29 |
Genentech, Inc. |
Nucleic acid intercalating agents
|
|
US5134066A
(en)
|
1989-08-29 |
1992-07-28 |
Monsanto Company |
Improved probes using nucleosides containing 3-dezauracil analogs
|
|
US5591722A
(en)
|
1989-09-15 |
1997-01-07 |
Southern Research Institute |
2'-deoxy-4'-thioribonucleosides and their antiviral activity
|
|
ATE190981T1
(de)
|
1989-10-24 |
2000-04-15 |
Isis Pharmaceuticals Inc |
2'-modifizierte nukleotide
|
|
US5130302A
(en)
|
1989-12-20 |
1992-07-14 |
Boron Bilogicals, Inc. |
Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same
|
|
US5670633A
(en)
|
1990-01-11 |
1997-09-23 |
Isis Pharmaceuticals, Inc. |
Sugar modified oligonucleotides that detect and modulate gene expression
|
|
US5681941A
(en)
|
1990-01-11 |
1997-10-28 |
Isis Pharmaceuticals, Inc. |
Substituted purines and oligonucleotide cross-linking
|
|
US5646265A
(en)
|
1990-01-11 |
1997-07-08 |
Isis Pharmceuticals, Inc. |
Process for the preparation of 2'-O-alkyl purine phosphoramidites
|
|
US5459255A
(en)
|
1990-01-11 |
1995-10-17 |
Isis Pharmaceuticals, Inc. |
N-2 substituted purines
|
|
US5587470A
(en)
|
1990-01-11 |
1996-12-24 |
Isis Pharmaceuticals, Inc. |
3-deazapurines
|
|
US5149797A
(en)
|
1990-02-15 |
1992-09-22 |
The Worcester Foundation For Experimental Biology |
Method of site-specific alteration of rna and production of encoded polypeptides
|
|
GB9009980D0
(en)
|
1990-05-03 |
1990-06-27 |
Amersham Int Plc |
Phosphoramidite derivatives,their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides
|
|
DE69032425T2
(de)
|
1990-05-11 |
1998-11-26 |
Microprobe Corp., Bothell, Wash. |
Teststreifen zum Eintauchen für Nukleinsäure-Hybridisierungsassays und Verfahren zur kovalenten Immobilisierung von Oligonucleotiden
|
|
US5614617A
(en)
|
1990-07-27 |
1997-03-25 |
Isis Pharmaceuticals, Inc. |
Nuclease resistant, pyrimidine modified oligonucleotides that detect and modulate gene expression
|
|
US5432272A
(en)
|
1990-10-09 |
1995-07-11 |
Benner; Steven A. |
Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
|
|
US6582908B2
(en)
|
1990-12-06 |
2003-06-24 |
Affymetrix, Inc. |
Oligonucleotides
|
|
ES2103918T3
(es)
|
1991-10-17 |
1997-10-01 |
Ciba Geigy Ag |
Nucleosidos biciclicos, oligonucleotidos, procedimiento para su obtencion y productos intermedios.
|
|
US5594121A
(en)
|
1991-11-07 |
1997-01-14 |
Gilead Sciences, Inc. |
Enhanced triple-helix and double-helix formation with oligomers containing modified purines
|
|
US5484908A
(en)
|
1991-11-26 |
1996-01-16 |
Gilead Sciences, Inc. |
Oligonucleotides containing 5-propynyl pyrimidines
|
|
TW393513B
(en)
|
1991-11-26 |
2000-06-11 |
Isis Pharmaceuticals Inc |
Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
|
|
JP3739785B2
(ja)
|
1991-11-26 |
2006-01-25 |
アイシス ファーマシューティカルズ，インコーポレイティド |
修飾されたピリミジンを含有するオリゴマーを使用する増強された三重らせんおよび二重らせんの成形
|
|
US5359044A
(en)
|
1991-12-13 |
1994-10-25 |
Isis Pharmaceuticals |
Cyclobutyl oligonucleotide surrogates
|
|
FR2687679B1
(fr)
|
1992-02-05 |
1994-10-28 |
Centre Nat Rech Scient |
Oligothionucleotides.
|
|
EP0577558A2
(de)
|
1992-07-01 |
1994-01-05 |
Ciba-Geigy Ag |
Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte
|
|
DE69404289T2
(de)
|
1993-03-30 |
1998-02-19 |
Sanofi Sa |
Acyclische nucleosid analoge und sie enthaltende oligonucleotidsequenzen
|
|
US5502177A
(en)
|
1993-09-17 |
1996-03-26 |
Gilead Sciences, Inc. |
Pyrimidine derivatives for labeled binding partners
|
|
US5801154A
(en)
|
1993-10-18 |
1998-09-01 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of multidrug resistance-associated protein
|
|
US5457187A
(en)
|
1993-12-08 |
1995-10-10 |
Board Of Regents University Of Nebraska |
Oligonucleotides containing 5-fluorouracil
|
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
|
US5596091A
(en)
|
1994-03-18 |
1997-01-21 |
The Regents Of The University Of California |
Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides
|
|
US5627053A
(en)
|
1994-03-29 |
1997-05-06 |
Ribozyme Pharmaceuticals, Inc. |
2'deoxy-2'-alkylnucleotide containing nucleic acid
|
|
US5525711A
(en)
|
1994-05-18 |
1996-06-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Pteridine nucleotide analogs as fluorescent DNA probes
|
|
US5597909A
(en)
|
1994-08-25 |
1997-01-28 |
Chiron Corporation |
Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
|
|
US6172045B1
(en)
|
1994-12-07 |
2001-01-09 |
Neorx Corporation |
Cluster clearing agents
|
|
US6908903B1
(en)
|
1994-12-07 |
2005-06-21 |
Aletheon Pharmaceuticals, Inc. |
Cluster clearing agents
|
|
US20030119724A1
(en)
|
1995-11-22 |
2003-06-26 |
Ts`O Paul O.P. |
Ligands to enhance cellular uptake of biomolecules
|
|
JP2000501414A
(ja)
|
1995-11-22 |
2000-02-08 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
生体分子の細胞取り込みを高めるリガンド
|
|
WO2005121370A2
(en)
|
2004-06-03 |
2005-12-22 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds that facilitate risc loading
|
|
US6620916B1
(en)
|
1996-09-26 |
2003-09-16 |
Ajinomoto Co., Inc. |
Modified physiologically active proteins and medicinal compositions containing the same
|
|
US6770748B2
(en)
|
1997-03-07 |
2004-08-03 |
Takeshi Imanishi |
Bicyclonucleoside and oligonucleotide analogue
|
|
JP3756313B2
(ja)
|
1997-03-07 |
2006-03-15 |
武 今西 |
新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
|
|
RU2243231C2
(ru)
*
|
1997-09-12 |
2004-12-27 |
Эксикон А/С |
Бициклические аналоги нуклеозидов, нуклеотидов и олигонуклеотидов
|
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
|
WO1999014226A2
(en)
|
1997-09-12 |
1999-03-25 |
Exiqon A/S |
Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
|
|
US20030228597A1
(en)
|
1998-04-13 |
2003-12-11 |
Cowsert Lex M. |
Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation
|
|
US6300319B1
(en)
|
1998-06-16 |
2001-10-09 |
Isis Pharmaceuticals, Inc. |
Targeted oligonucleotide conjugates
|
|
US6043352A
(en)
|
1998-08-07 |
2000-03-28 |
Isis Pharmaceuticals, Inc. |
2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides
|
|
IL145778A0
(en)
|
1999-04-21 |
2002-07-25 |
American Home Prod |
Methods and compositions for inhibiting the function of polynucleotide sequences
|
|
CN102180924A
(zh)
|
1999-05-04 |
2011-09-14 |
桑塔里斯制药公司 |
L-核糖-lna类似物
|
|
US6525191B1
(en)
|
1999-05-11 |
2003-02-25 |
Kanda S. Ramasamy |
Conformationally constrained L-nucleosides
|
|
US8877916B2
(en)
|
2000-04-26 |
2014-11-04 |
Ceres, Inc. |
Promoter, promoter control elements, and combinations, and uses thereof
|
|
US9029523B2
(en)
|
2000-04-26 |
2015-05-12 |
Ceres, Inc. |
Promoter, promoter control elements, and combinations, and uses thereof
|
|
US6383812B1
(en)
|
1999-05-28 |
2002-05-07 |
Academia Sinica |
Anti liver disease drug R-YEEE and method of synthesizing branched galactose-terminal glycoproteins
|
|
US20080281041A1
(en)
|
1999-06-07 |
2008-11-13 |
Rozema David B |
Reversibly Masked Polymers
|
|
US8541548B2
(en)
|
1999-06-07 |
2013-09-24 |
Arrowhead Madison Inc. |
Compounds and methods for reversible modification of biologically active molecules
|
|
WO2001023616A2
(en)
|
1999-09-29 |
2001-04-05 |
Genetic Vectors, Inc. |
Method of identifying pathogenic cryptococci
|
|
US20050112118A1
(en)
*
|
1999-12-02 |
2005-05-26 |
Myriad Genetics, Incorporated |
Compositions and methods for treating inflammatory disorders
|
|
EP1244667B1
(en)
|
1999-12-30 |
2006-04-05 |
K.U. Leuven Research & Development |
Cyclohexene nucleic acids
|
|
US20020055479A1
(en)
|
2000-01-18 |
2002-05-09 |
Cowsert Lex M. |
Antisense modulation of PTP1B expression
|
|
US7179796B2
(en)
|
2000-01-18 |
2007-02-20 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of PTP1B expression
|
|
US6602857B1
(en)
|
2000-01-18 |
2003-08-05 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of PTP1B expression
|
|
US6261840B1
(en)
|
2000-01-18 |
2001-07-17 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of PTP1B expression
|
|
US7491805B2
(en)
|
2001-05-18 |
2009-02-17 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery
|
|
US20040241651A1
(en)
|
2000-04-07 |
2004-12-02 |
Alexander Olek |
Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations
|
|
US6906182B2
(en)
|
2000-12-01 |
2005-06-14 |
Cell Works Therapeutics, Inc. |
Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and method of use
|
|
WO2002087541A1
(en)
|
2001-04-30 |
2002-11-07 |
Protiva Biotherapeutics Inc. |
Lipid-based formulations for gene transfer
|
|
JP2005504020A
(ja)
|
2001-07-03 |
2005-02-10 |
アイシス・ファーマシューティカルス・インコーポレーテッド |
ヌクレアーゼ耐性キメラオリゴヌクレオチド
|
|
US20040215006A1
(en)
*
|
2003-04-25 |
2004-10-28 |
Isis Pharmaceuticals Inc. |
Modulation of tyrosinase expression
|
|
US20100240730A1
(en)
|
2002-02-20 |
2010-09-23 |
Merck Sharp And Dohme Corp. |
RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
|
|
EP1539689A2
(en)
*
|
2002-07-19 |
2005-06-15 |
Pharmacia Corporation |
Antisense modulation of endothelial lipase expression
|
|
WO2004011624A2
(en)
|
2002-07-31 |
2004-02-05 |
Nucleonics, Inc. |
Double stranded rna structures and constructs, and methods for generating and using the same
|
|
EP1543019A2
(en)
|
2002-09-11 |
2005-06-22 |
Santaris Pharma A/S |
Modified pna molecules
|
|
US20060035344A1
(en)
|
2002-10-18 |
2006-02-16 |
Pachuk Catherine J |
Double-stranded rna structures and constructs, and methods for generating and using the same
|
|
WO2004044136A2
(en)
|
2002-11-05 |
2004-05-27 |
Isis Pharmaceuticals, Inc. |
Compositions comprising alternating 2’-modified nucleosides for use in gene modulation
|
|
AU2003291753B2
(en)
|
2002-11-05 |
2010-07-08 |
Isis Pharmaceuticals, Inc. |
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
|
US7250496B2
(en)
|
2002-11-14 |
2007-07-31 |
Rosetta Genomics Ltd. |
Bioinformatically detectable group of novel regulatory genes and uses thereof
|
|
EP1560931B1
(en)
|
2002-11-14 |
2011-07-27 |
Dharmacon, Inc. |
Functional and hyperfunctional sirna
|
|
US7314750B2
(en)
*
|
2002-11-20 |
2008-01-01 |
Affymetrix, Inc. |
Addressable oligonucleotide array of the rat genome
|
|
US7144999B2
(en)
*
|
2002-11-23 |
2006-12-05 |
Isis Pharmaceuticals, Inc. |
Modulation of hypoxia-inducible factor 1 alpha expression
|
|
US6673661B1
(en)
|
2002-12-20 |
2004-01-06 |
Taiwan Semiconductor Manufacturing Co., Ltd. |
Self-aligned method for forming dual gate thin film transistor (TFT) device
|
|
US20070015927A1
(en)
|
2003-01-09 |
2007-01-18 |
Kim Byeang H |
New phosphoramidite compounds
|
|
US7846906B2
(en)
|
2003-02-28 |
2010-12-07 |
Isis Pharmaceuticals, Inc. |
Modulation of growth hormone receptor expression and insulin-like growth factor expression
|
|
US7803781B2
(en)
*
|
2003-02-28 |
2010-09-28 |
Isis Pharmaceuticals, Inc. |
Modulation of growth hormone receptor expression and insulin-like growth factor expression
|
|
AU2004233092C9
(en)
|
2003-04-17 |
2010-10-28 |
Alnylam Pharmaceuticals, Inc. |
Modified iRNA agents
|
|
US7851615B2
(en)
|
2003-04-17 |
2010-12-14 |
Alnylam Pharmaceuticals, Inc. |
Lipophilic conjugated iRNA agents
|
|
US7723509B2
(en)
|
2003-04-17 |
2010-05-25 |
Alnylam Pharmaceuticals |
IRNA agents with biocleavable tethers
|
|
US7399853B2
(en)
|
2003-04-28 |
2008-07-15 |
Isis Pharmaceuticals |
Modulation of glucagon receptor expression
|
|
US7750142B2
(en)
|
2003-04-28 |
2010-07-06 |
Isis Pharmaceuticals, Inc. |
Modulation of glucagon receptor expression
|
|
WO2004101619A1
(ja)
|
2003-05-15 |
2004-11-25 |
Shionogi Co., Ltd. |
機能的糖ペプチドの合理的設計および合成
|
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
|
ATE555118T1
(de)
|
2003-08-28 |
2012-05-15 |
Takeshi Imanishi |
Neue synthetische nukleidsäuren vom typ mit quervernetzter n-o-bindung
|
|
JP5379347B2
(ja)
|
2003-09-18 |
2013-12-25 |
アイシス ファーマシューティカルズ， インコーポレーテッド |
４’−チオヌクレオシドおよびオリゴマー化合物
|
|
WO2005065686A1
(en)
|
2004-01-07 |
2005-07-21 |
Adipogen Pharmaceuticals Pty Limited |
Differentiation modulating agents and uses therefor
|
|
EP2363480A3
(en)
|
2004-01-20 |
2015-10-07 |
Isis Pharmaceuticals, Inc. |
Modulation of glucocorticoid receptor expression
|
|
JP5192234B2
(ja)
|
2004-08-10 |
2013-05-08 |
アルナイラム ファーマシューティカルズ， インコーポレイテッド |
化学修飾オリゴヌクレオチド
|
|
US20090203132A1
(en)
|
2004-09-09 |
2009-08-13 |
Swayze Eric E |
Pyrrolidinyl groups for attaching conjugates to oligomeric compounds
|
|
US20060089325A1
(en)
|
2004-10-13 |
2006-04-27 |
Sanjay Bhanot |
Antisense modulation of PTP1B expression
|
|
WO2006047842A2
(en)
|
2004-11-08 |
2006-05-11 |
K.U. Leuven Research And Development |
Modified nucleosides for rna interference
|
|
US20060148740A1
(en)
|
2005-01-05 |
2006-07-06 |
Prosensa B.V. |
Mannose-6-phosphate receptor mediated gene transfer into muscle cells
|
|
EP1841867A1
(en)
|
2005-01-24 |
2007-10-10 |
Avaris AB |
COMPLEX CONTAINING SiRNA, ShRNA OR ANTISENSE MOLECULE AND FUNCTIONAL ENTITY, FOR IMPROVED SPECIFICITY AND DELIVERY
|
|
EP2388326A1
(en)
|
2005-09-19 |
2011-11-23 |
Isis Pharmaceuticals, Inc. |
Modulation of glucagon receptor expression
|
|
EP1941040A1
(en)
|
2005-09-19 |
2008-07-09 |
Johnson & Johnson Pharmaceutical Research & Development L.L.C. |
Modulation of glucocorticoid receptor expression
|
|
JP5342881B2
(ja)
|
2006-01-27 |
2013-11-13 |
アイシス ファーマシューティカルズ， インコーポレーテッド |
６−修飾された二環式核酸類似体
|
|
US7569686B1
(en)
|
2006-01-27 |
2009-08-04 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for synthesis of bicyclic nucleic acid analogs
|
|
US8178503B2
(en)
|
2006-03-03 |
2012-05-15 |
International Business Machines Corporation |
Ribonucleic acid interference molecules and binding sites derived by analyzing intergenic and intronic regions of genomes
|
|
US7901882B2
(en)
*
|
2006-03-31 |
2011-03-08 |
Affymetrix, Inc. |
Analysis of methylation using nucleic acid arrays
|
|
EP2505646A1
(en)
|
2006-05-05 |
2012-10-03 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for modulating expression of CRP
|
|
US7547684B2
(en)
|
2006-05-11 |
2009-06-16 |
Isis Pharmaceuticals, Inc. |
5′-modified bicyclic nucleic acid analogs
|
|
US7666854B2
(en)
|
2006-05-11 |
2010-02-23 |
Isis Pharmaceuticals, Inc. |
Bis-modified bicyclic nucleic acid analogs
|
|
CN101500548A
(zh)
|
2006-08-18 |
2009-08-05 |
弗·哈夫曼-拉罗切有限公司 |
用于体内递送多核苷酸的多缀合物
|
|
US8658211B2
(en)
|
2006-08-18 |
2014-02-25 |
Arrowhead Madison Inc. |
Polyconjugates for in vivo delivery of polynucleotides
|
|
WO2008101157A1
(en)
|
2007-02-15 |
2008-08-21 |
Isis Pharmaceuticals, Inc. |
5'-substituted-2'-f modified nucleosides and oligomeric compounds prepared therefrom
|
|
EP2129402A2
(en)
|
2007-02-16 |
2009-12-09 |
KTB Tumorforschungsgesellschaft mbH |
Receptor and antigen targeted prodrug
|
|
US8877917B2
(en)
|
2007-04-23 |
2014-11-04 |
Alnylam Pharmaceuticals, Inc. |
Glycoconjugates of RNA interference agents
|
|
EP2170917B1
(en)
|
2007-05-30 |
2012-06-27 |
Isis Pharmaceuticals, Inc. |
N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
|
|
EP2173760B2
(en)
|
2007-06-08 |
2015-11-04 |
Isis Pharmaceuticals, Inc. |
Carbocyclic bicyclic nucleic acid analogs
|
|
US20090004140A1
(en)
|
2007-06-26 |
2009-01-01 |
Yao-Ling Qiu |
4-substituted pyrrolidine as anti-infectives
|
|
CA2692579C
(en)
|
2007-07-05 |
2016-05-03 |
Isis Pharmaceuticals, Inc. |
6-disubstituted bicyclic nucleic acid analogs
|
|
WO2009046141A2
(en)
|
2007-10-01 |
2009-04-09 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of fibroblast growth factor receptor 4 expression
|
|
NZ585250A
(en)
|
2007-11-09 |
2012-06-29 |
Isis Pharmaceuticals Inc |
Antisense modulation of factor 7 expression
|
|
WO2009067647A1
(en)
|
2007-11-21 |
2009-05-28 |
Isis Pharmaceuticals, Inc. |
Carbocyclic alpha-l-bicyclic nucleic acid analogs
|
|
EP4074344A1
(en)
*
|
2007-12-04 |
2022-10-19 |
Arbutus Biopharma Corporation |
Targeting lipids
|
|
JP2011511004A
(ja)
|
2008-01-31 |
2011-04-07 |
アルナイラム ファーマシューティカルズ インコーポレイテッド |
ＰＣＳＫ９遺伝子を標的とするｄｓＲＮＡを送達するための最適化された方法
|
|
EP2265627A2
(en)
|
2008-02-07 |
2010-12-29 |
Isis Pharmaceuticals, Inc. |
Bicyclic cyclohexitol nucleic acid analogs
|
|
WO2009142822A2
(en)
|
2008-03-26 |
2009-11-26 |
Alnylam Pharmaceuticals, Inc. |
2-f modified rna interference agents
|
|
EP2274425A2
(en)
|
2008-04-11 |
2011-01-19 |
Alnylam Pharmaceuticals Inc. |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
|
WO2009143369A2
(en)
|
2008-05-22 |
2009-11-26 |
Isis Pharmaceuticals, Inc. |
Method of preparing nucleosides and analogs thereof without using chromatography
|
|
JP2012513953A
(ja)
|
2008-09-23 |
2012-06-21 |
アルニラム ファーマスーティカルズ インコーポレイテッド |
付加環化を用いたモノマーおよびオリゴヌクレオチドの化学修飾
|
|
WO2010036698A1
(en)
|
2008-09-24 |
2010-04-01 |
Isis Pharmaceuticals, Inc. |
Substituted alpha-l-bicyclic nucleosides
|
|
EP2361256B1
(en)
|
2008-09-24 |
2013-04-10 |
Isis Pharmaceuticals, Inc. |
Cyclohexenyl nucleic acid analogs
|
|
AU2009305636A1
(en)
|
2008-10-15 |
2010-04-22 |
Ionis Pharmaceuticals, Inc. |
Modulation of Factor 11 expression
|
|
EA037404B1
(ru)
|
2008-11-10 |
2021-03-24 |
Арбутус Биофарма Корпорэйшн |
Липиды и композиции для доставки лекарственных средств
|
|
EP2391343B1
(en)
|
2009-01-29 |
2017-03-01 |
Arbutus Biopharma Corporation |
Improved lipid formulation for the delivery of nucleic acids
|
|
MX2011010930A
(es)
|
2009-04-15 |
2012-04-30 |
Isis Pharmaceuticals Inc |
Modulacion de respuestas inflamatorias a través de factor xi.
|
|
CA3042927C
(en)
|
2009-05-05 |
2022-05-17 |
Arbutus Biopharma Corporation |
Lipid compositions for the delivery of therapeutic agents
|
|
HRP20211619T1
(hr)
|
2009-06-10 |
2022-02-04 |
Arbutus Biopharma Corporation |
Poboljšana formulacija lipida
|
|
NZ597504A
(en)
|
2009-06-15 |
2013-10-25 |
Alnylam Pharmaceuticals Inc |
Lipid formulated dsrna targeting the pcsk9 gene
|
|
EP2454369A4
(en)
|
2009-07-16 |
2013-07-03 |
Isis Pharmaceuticals Inc |
MODULATION OF FACTOR 7 EXPRESSION
|
|
EP2462153B1
(en)
|
2009-08-06 |
2015-07-29 |
Isis Pharmaceuticals, Inc. |
Bicyclic cyclohexose nucleic acid analogs
|
|
WO2011038356A2
(en)
|
2009-09-25 |
2011-03-31 |
Johns Hopkins University |
Novel liver-targeting agents and their synthesis
|
|
TWI388338B
(zh)
|
2009-10-26 |
2013-03-11 |
Iner Aec Executive Yuan |
對聚合醣鏈進行放射標誌以作為肝受體造影劑之方法
|
|
TWI391144B
(zh)
|
2009-10-26 |
2013-04-01 |
Iner Aec Executive Yuan |
一種定量肝殘餘功能的檢驗方法與其新穎肝受體造影檢驗藥劑
|
|
WO2011072290A2
(en)
|
2009-12-11 |
2011-06-16 |
The Regents Of The University Of Michigan |
Targeted dendrimer-drug conjugates
|
|
US9198972B2
(en)
|
2010-01-28 |
2015-12-01 |
Alnylam Pharmaceuticals, Inc. |
Monomers and oligonucleotides comprising cycloaddition adduct(s)
|
|
US20130059902A1
(en)
|
2010-02-08 |
2013-03-07 |
Isis Pharmaceuticals, Inc. |
Methods and compositions useful in treatment of diseases or conditions related to repeat expansion
|
|
NZ601737A
(en)
|
2010-02-24 |
2013-06-28 |
Arrowhead Res Corp |
Compositions for targeted delivery of sirna
|
|
US9193752B2
(en)
|
2010-03-17 |
2015-11-24 |
Isis Pharmaceuticals, Inc. |
5′-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom
|
|
US8349308B2
(en)
|
2010-03-26 |
2013-01-08 |
Mersana Therapeutics, Inc. |
Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof
|
|
US20130109817A1
(en)
|
2010-03-26 |
2013-05-02 |
Mersana Therapeutics, Inc. |
Modified Polymers for Delivery of Polynucleotides, Method of Manufacture, and Methods of Use Thereof
|
|
US9102938B2
(en)
*
|
2010-04-01 |
2015-08-11 |
Alnylam Pharmaceuticals, Inc. |
2′ and 5′ modified monomers and oligonucleotides
|
|
WO2011139702A2
(en)
|
2010-04-28 |
2011-11-10 |
Isis Pharmaceuticals, Inc. |
Modified nucleosides and oligomeric compounds prepared therefrom
|
|
US20130236968A1
(en)
|
2010-06-21 |
2013-09-12 |
Alnylam Pharmaceuticals, Inc. |
Multifunctional copolymers for nucleic acid delivery
|
|
JP2013541334A
(ja)
*
|
2010-09-15 |
2013-11-14 |
アルニラム ファーマスーティカルズ インコーポレイテッド |
修飾されたｉＲＮＡ剤
|
|
WO2012068187A1
(en)
|
2010-11-19 |
2012-05-24 |
Merck Sharp & Dohme Corp. |
Poly(amide) polymers for the delivery of oligonucleotides
|
|
EP3192800A1
(en)
|
2010-12-17 |
2017-07-19 |
Arrowhead Pharmaceuticals, Inc. |
Galactose cluster-pharmacokinetic modulator targeting moiety for sirna
|
|
US8501930B2
(en)
|
2010-12-17 |
2013-08-06 |
Arrowhead Madison Inc. |
Peptide-based in vivo siRNA delivery system
|
|
BR122020024394B1
(pt)
|
2010-12-29 |
2021-05-11 |
F. Hoffmann-La Roche Ag |
conjugado e composição farmacêutica
|
|
PE20142463A1
(es)
|
2011-04-01 |
2015-01-22 |
Isis Pharmaceuticals Inc |
Modulacion de la expresion del transductor de senales y activador de la transcripcion 3 (stat3)
|
|
CN105886506A
(zh)
|
2011-04-13 |
2016-08-24 |
Isis制药公司 |
Ptp1b 表达的反义调节
|
|
AU2012271357A1
(en)
|
2011-06-16 |
2013-05-02 |
Ionis Pharmaceuticals, Inc. |
Antisense modulation of fibroblast growth factor receptor 4 expression
|
|
RU2631805C2
(ru)
|
2011-06-21 |
2017-09-26 |
Элнилэм Фармасьютикалз, Инк. |
Композиции и способы ингибирования экспрессии генов аполипопротеина с-iii (арос3)
|
|
JP2014531476A
(ja)
|
2011-08-26 |
2014-11-27 |
アローヘッド リサーチ コーポレイション |
インビボ核酸送達のためのポリ（ビニルエステル）ポリマー
|
|
WO2013033230A1
(en)
*
|
2011-08-29 |
2013-03-07 |
Isis Pharmaceuticals, Inc. |
Oligomer-conjugate complexes and their use
|
|
EP2758533B1
(en)
|
2011-09-20 |
2018-04-11 |
Ionis Pharmaceuticals, Inc. |
Antisense modulation of gcgr expression
|
|
US8901098B2
(en)
|
2011-10-25 |
2014-12-02 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of GCCR expression
|
|
PE20142362A1
(es)
|
2011-11-18 |
2015-01-30 |
Alnylam Pharmaceuticals Inc |
Agentes de iarn, composiciones y metodos de uso de los mismos para tratar enfermedades asociadas con transtiretina (ttr)
|
|
EP2809400B1
(en)
*
|
2012-02-03 |
2018-11-07 |
Antisense Therapeutics Ltd |
Combination therapy comprising a growth hormone variant and an oligonucleotide targeted to the growth hormone receptor
|
|
WO2013119979A1
(en)
|
2012-02-08 |
2013-08-15 |
Isis Pharmaceuticals, Inc. |
Methods and compositions for modulating factor vii expression
|
|
US9133461B2
(en)
*
|
2012-04-10 |
2015-09-15 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of the ALAS1 gene
|
|
EP3358013B1
(en)
|
2012-05-02 |
2020-06-24 |
Sirna Therapeutics, Inc. |
Short interfering nucleic acid (sina) compositions
|
|
TW201808342A
(zh)
|
2012-05-02 |
2018-03-16 |
喜納製藥公司 |
包含四ｇａｌｎａｃ之新穎結合物及傳送寡核苷酸之方法
|
|
BR112014028645A2
(pt)
|
2012-05-16 |
2017-06-27 |
Rana Therapeutics Inc |
composições e métodos para modulação da expressão de apoa1 e abca1.
|
|
JP2016528873A
(ja)
|
2012-05-16 |
2016-09-23 |
ラナ セラピューティクス インコーポレイテッド |
遺伝子発現を調節するための組成物及び方法
|
|
KR20160074368A
(ko)
|
2012-05-16 |
2016-06-28 |
라나 테라퓨틱스, 인크. |
Utrn 발현을 조절하기 위한 조성물 및 방법
|
|
RU2015119411A
(ru)
|
2012-11-15 |
2017-01-10 |
Рош Инновейшен Сентер Копенгаген А/С |
Конъюгаты антисмысловых соединений, направленные на аполипопротеин в
|
|
WO2014118272A1
(en)
|
2013-01-30 |
2014-08-07 |
Santaris Pharma A/S |
Antimir-122 oligonucleotide carbohydrate conjugates
|
|
PL2992098T3
(pl)
|
2013-05-01 |
2019-09-30 |
Ionis Pharmaceuticals, Inc. |
Kompozycje i sposoby modulowania ekspresji hbv i ttr
|
|
AU2014284152B2
(en)
|
2013-06-21 |
2020-01-23 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for modulation of target nucleic acids
|
|
SG10201908122XA
(en)
|
2013-06-27 |
2019-10-30 |
Roche Innovation Ct Copenhagen As |
Antisense oligomers and conjugates targeting pcsk9
|
|
EP3730614A3
(en)
|
2013-07-02 |
2020-12-30 |
Ionis Pharmaceuticals, Inc. |
Modulators of growth hormone receptor
|
|
US9943604B2
(en)
|
2013-09-20 |
2018-04-17 |
Ionis Pharmaceuticals, Inc. |
Targeted therapeutic nucleosides and their use
|
|
KR20160083876A
(ko)
|
2013-11-14 |
2016-07-12 |
로슈 이노베이션 센터 코펜하겐 에이/에스 |
ApoB 안티센스 접합체 화합물
|
|
PH12016502062B1
(en)
|
2014-05-01 |
2023-01-27 |
Ionis Pharmaceuticals Inc |
Compositions and methods for modulating complement factor b expression
|
|
EP4534092A3
(en)
|
2014-05-01 |
2025-07-02 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for modulating pkk expression
|
|
EP4223315A3
(en)
|
2014-05-01 |
2023-08-23 |
Ionis Pharmaceuticals, Inc. |
Method for synthesis of reactive conjugate clusters
|
|
MX373283B
(es)
|
2014-05-01 |
2020-05-20 |
Ionis Pharmaceuticals Inc |
Composiciones y metodos para modular la expresion del receptor de la hormona del crecimiento.
|
|
EP3137605B1
(en)
|
2014-05-01 |
2020-10-28 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for modulating angiopoietin-like 3 expression
|
|
US10570169B2
(en)
*
|
2014-05-22 |
2020-02-25 |
Ionis Pharmaceuticals, Inc. |
Conjugated antisense compounds and their use
|
|
US20170145424A1
(en)
*
|
2014-06-06 |
2017-05-25 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for enhanced intestinal absorption of conjugated oligomeric compounds
|
|
US9778708B1
(en)
|
2016-07-18 |
2017-10-03 |
Lenovo Enterprise Solutions (Singapore) Pte. Ltd. |
Dual sided latching retainer for computer modules
|